Special Issues

Special Issue Title: Present and future of tricuspid regurgitation

· Print Special Issue Flyer

· Deadline for manuscript submissions: 1 January 2022

Special Issue Editor

Guest Editor

        Dr. Antonio Mangieri

        Humanitas Research Hospital IRCCS, Rozzano-Milan, Italy  

Website | E-Mail

Interests: Percutaneous tricuspid interventions; Conduction disturbances after TAVI; Antithrombotic therapy in TAVI patients; Percutaneous treatment of bicuspid valve

        Azeem Latib

        Montefiore Medical Center Moses Division, New York, NY, USA

Website | E-Mail

Interests:  Tricuspid valve intervention; Aortic valve intervention; Mitral valve intervention

Special Issue Information

Dear Colleagues,

The tricuspid valve is progressively gaining importance thanks to the new evidences which corroborates the prognostic importance of both organic and functional tricuspid regurgitation (FTR). In particular, if left untreated, FTR is not a simple bystander but contributes to the progressive deterioration of right ventricular function and to the systemic congestion syndrome which characterizes this valvulopathy. Surgery represents the gold standard for the correction of both functional and organic TR, however surgical repair/replacement of tricuspid valve is limited by a high morbidity and mortality rate. In this setting, new percutaneous treatments are under development to address this unmet clinical need. This special issue will give a comprensive overview of the problem focusing on the clinical aspects related to tricuspid valve disease as well as on the surgical and percutaneous treatments that are currently available and that will be developed in the near future. 

Dr. Antonio Mangieri and Azeem Latib

Guest Editor


Manuscript Submission Information

Manuscripts should be submitted online at https://rcm.imrpress.org by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Reviews in Cardiovascular Medicine is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1950. Submitted papers should be well formatted and use good English.


Tricuspid regurgitation; Right heart failure; Transcatheter tricuspid valve replacement; Transcatheter tricuspid valve repair 

Share This Special Issue


Planned Papers

Title: Epidemiology and physiopathology of tricuspid regurgitation

Title: Prognostic value of tricuspid regurgitation

Title: Multi-modality imaging of the tricuspid valve 

Title: Tricuspid valve surgery: the history and the future

Title: Percutaneous tricuspid valve repair

Title: Percutaneous tricuspid valve replacement

Please wait a minute...
For Selected: Toggle Thumbnails

Current Issue

  • Volume 22, Issue 3